These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38716597)
1. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia]. Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597 [No Abstract] [Full Text] [Related]
2. [Effects of minimal residual disease level on day 33 of remission induction and IKZF1 genotype on the survival of children with B-lineage acute lymphoblastic leukemia]. Kuang WY; Zheng MC; Li WL; Yang HX; Zhang BS; Wu P Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul; 20(7):538-542. PubMed ID: 30022754 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance and treatment strategies for IKZF1 deletion in pediatric B-cell precursor acute lymphoblastic leukemia. Pan L; Chen Y; Weng K; Guo B; Zhuang S; Huang S; Lian Z; Wang X; Li N; Zheng Y BMC Cancer; 2024 Aug; 24(1):1070. PubMed ID: 39210321 [TBL] [Abstract][Full Text] [Related]
6. Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia. Volejnikova J; Mejstrikova E; Dörge P; Meissner B; Zimmermannova O; Svojgr K; Stanulla M; Cario G; Schrappe M; Stary J; Hrusak O; Trka J; Fronkova E Pediatr Blood Cancer; 2013 Mar; 60(3):420-7. PubMed ID: 22997141 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of IKZF1 deletions and IKZF1 Braun M; Pastorczak A; Sędek Ł; Taha J; Madzio J; Jatczak-Pawlik I; Wypyszczak K; Matysiak M; Derwich K; Lejman M; Kazanowska B; Szczepański T; Kowalczyk JR; Mlynarski W; Hematol Oncol; 2022 Aug; 40(3):430-441. PubMed ID: 35118711 [TBL] [Abstract][Full Text] [Related]
8. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013. Olsson L; Ivanov Öfverholm I; Norén-Nyström U; Zachariadis V; Nordlund J; Sjögren H; Golovleva I; Nordgren A; Paulsson K; Heyman M; Barbany G; Johansson B Br J Haematol; 2015 Sep; 170(6):847-58. PubMed ID: 26018335 [TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia. Yao QM; Liu KY; Gale RP; Jiang B; Liu YR; Jiang Q; Jiang H; Zhang XH; Zhang MJ; Chen SS; Huang XJ; Xu LP; Ruan GR BMC Cancer; 2016 Apr; 16():269. PubMed ID: 27067989 [TBL] [Abstract][Full Text] [Related]
10. Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study. Michels N; Boer JM; Enshaei A; Sutton R; Heyman M; Ebert S; Fiocco M; de Groot-Kruseman HA; van der Velden VHJ; Barbany G; Escherich G; Vora A; Trahair T; Dalla-Pozza L; Pieters R; Zur Stadt U; Schmiegelow K; Moorman AV; Zwaan CM; den Boer ML Lancet Haematol; 2021 Oct; 8(10):e700-e710. PubMed ID: 34560013 [TBL] [Abstract][Full Text] [Related]
11. [Prognostic significance of IKZF1 gene deletions in patients with B-cell acute lymphoblastic leukemia]. Tang BQ; Cai ZH; Lin DN; Wang ZX; Liang XJ; Fan ZP; Huang F; Liu QF; Zhou HS Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):235-240. PubMed ID: 35405782 [No Abstract] [Full Text] [Related]
12. Combination of IKZF1 deletion and early molecular response show significant roles on prognostic stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia patients. Li H; Zhang W; Kuang P; Ye Y; Yang J; Dai Y; Lu X; Zheng Y; Liu T Leuk Lymphoma; 2018 Aug; 59(8):1890-1898. PubMed ID: 29214878 [TBL] [Abstract][Full Text] [Related]
13. Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia. Waanders E; van der Velden VH; van der Schoot CE; van Leeuwen FN; van Reijmersdal SV; de Haas V; Veerman AJ; van Kessel AG; Hoogerbrugge PM; Kuiper RP; van Dongen JJ Leukemia; 2011 Feb; 25(2):254-8. PubMed ID: 21102428 [TBL] [Abstract][Full Text] [Related]
14. Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia. Sutton R; Shaw PJ; Venn NC; Law T; Dissanayake A; Kilo T; Haber M; Norris MD; Fraser C; Alvaro F; Revesz T; Trahair TN; Dalla-Pozza L; Marshall GM; O'Brien TA Br J Haematol; 2015 Feb; 168(3):395-404. PubMed ID: 25312094 [TBL] [Abstract][Full Text] [Related]
15. Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia. Mangum DS; Meyer JA; Mason CC; Shams S; Maese LD; Gardiner JD; Downie JM; Pei D; Cheng C; Gleason A; Luo M; Pui CH; Aplenc R; Hunger SP; Loh M; Greaves M; Trede N; Raetz E; Frazer JK; Mullighan CG; Engel ME; Miles RR; Rabin KR; Schiffman JD JAMA Oncol; 2021 Oct; 7(10):1521-1528. PubMed ID: 34410295 [TBL] [Abstract][Full Text] [Related]
16. Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL. Kim M; Park J; Kim DW; Kim YJ; Jeon YW; Yoon JH; Shin SH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim HJ; Min CK; Cho SG; Kim Y; Lee JW; Han K; Min WS; Lee S Bone Marrow Transplant; 2015 Mar; 50(3):354-62. PubMed ID: 25501350 [TBL] [Abstract][Full Text] [Related]
17. [Effect of increasing the intensity of chemotherapy on the prognosis of acute lymphoblastic leukemia in children with IKZF1 deletion]. Zheng YZ; Li J; LE SH; Zheng H; Hua XL; Chen ZS; Hu JD Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jul; 21(7):690-695. PubMed ID: 31315770 [TBL] [Abstract][Full Text] [Related]
18. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure. Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785 [TBL] [Abstract][Full Text] [Related]
19. Aberrant IKZF1 gene as relapse predictor in standard-risk pediatric patients with B-cell precursor acute lymphoblastic leukaemia. Vshyukova VS; Krasko OV; Yanchanka DA; Meleshko AN Int J Lab Hematol; 2022 Aug; 44(4):769-776. PubMed ID: 35505470 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis. Zhang W; Kuang P; Li H; Wang F; Wang Y Ann Hematol; 2017 Feb; 96(2):215-225. PubMed ID: 27815723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]